1. McKelvey W, Gwynn RC, Jeffery N, Kass D, Thorpe LE, Rk G, Palmer CD, Parsons PJ. A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect. 2007; 115:1435–1441. PMID:
17938732.
2. Chen X, Zhou H, Li X, Wang Z, Zhu G, Jin T. Effects of lead and cadmium co-exposure on hemoglobin in a Chinese population. Environ Toxicol Pharmacol. 2015; 39:758–763. DOI:
10.1016/j.etap.2015.02.005. PMID:
25727170.
3. Kang SK, Hong JP, Kim KW, Jang JY, Chung HK, Chung KC. Assessment of occupational exposure to cadmium in Korea. Korean J Occup Environ Med. 1994; 6:252–258.
4. Cho S, Kim YL, Kim SR, Cho DK, Kim YJ, Kang SK. Cadmium intoxication and its effects on kidney function. Korean J Nephrol. 2001; 20:1004–1013.
5. Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med. 1995; 52:73–81. DOI:
10.1136/oem.52.2.73. PMID:
7757170.
6. Lee CK, Kim YB, Lee GS, Hwang KY, Kim HS, Lee SS, Ahn KD, Lee BK. The effect of smoking and drinking habit on the health status of lead workers. Korean J Prev Med. 1998; 31:708–718.
7. Park JU, Oh SW, Kim SH, Kim YH, Park RJ, Moon JD. A study on the association between blood lead levels and habitual tobacco and alcohol use in Koreans with no occupational lead exposure. Korean J Occup Environ Med. 2008; 20:165–173.
8. Yoo IY. The blood levels of lead, mercury, and cadmium and metabolic syndrome of Korean adults. J Korean Soc Living Environ Sys. 2014; 21:251–259. DOI:
10.21086/ksles.2014.04.21.2.251.
9. Lee KJ, Kim JJ, Hwang JH, Kim KY. Background exposure of healthy office worker to cadmium in selected Korean women. J Korean Soc Occup Environ Hyg. 2008; 18:108–114.
10. Nordberg GF. Current issues in low-dose cadmium toxicology: nephrotoxicity and carcinogenicity. Environ Sci. 1996; 4:133–147.
11. Wu X, Liang Y, Jin T, Ye T, Kong Q, Wang Z, Lei L, Bergdahl IA, Nordberg GF. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice. Environ Res. 2008; 108:233–238. DOI:
10.1016/j.envres.2008.02.011. PMID:
18692183.
12. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect. 1991; 91:33–37. DOI:
10.1289/ehp.919133. PMID:
2040248.
13. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect. 1997; 105:928–938. DOI:
10.1289/ehp.97105928. PMID:
9300927.
14. Cooper WC. Deaths from chronic renal disease in U.S. battery and lead production workers. Environ Health Perspect. 1988; 78:61–63. DOI:
10.1289/ehp.887861. PMID:
3203648.
15. Schuhmacher M, Paternain JL, Domingo JL, Corbella J. An assessment of some biomonitors indicative of occupational exposure to lead. Trace Elem Electrolyte. 1997; 14:145–149.
16. Gurer-Orhan H, Sabir HU, Ozgunes H. Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicology. 2004; 195:147–154. DOI:
10.1016/j.tox.2003.09.009. PMID:
14751670.
18. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect. 2007; 115:472–482. DOI:
10.1289/ehp.9785. PMID:
17431501.
19. Elinder CG, Ediling C, Lindberg E, Kagedal B, Vesterberg O. Assessment of renal function in workers previously exposed to cadmium. Br J Ind Med. 1985; 42:754–760. PMID:
3904816.
20. Kim NH, Hyun YY, Lee YB, Chang YS, Rhu SH, Oh KH, Ahn C. Environmental heavy metal exposure and chronic kidney disease in the general population. J Korean Med Sci. 2015; 30:272–277. DOI:
10.3346/jkms.2015.30.3.272. PMID:
25729249.
21. Lee MS, Park SK, Hu H, Lee S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ Res. 2011; 111:171–176. DOI:
10.1016/j.envres.2010.10.006. PMID:
21055738.
22. Jung KS, Kim NS, Ahn SC, Lee BK. Relationship between urine cadmium and bone mineral density of residents around abandoned metal mines. Korean J Environ Health Sci. 2012;38:323–31.
23. Weiss ST, Munoz A, Stein A, Sparrow D, Speizer FE. The relationship of blood lead to blood pressure in a longitudinal study of working men. Am J Epidemiol. 1986; 123:800–808. DOI:
10.1093/oxfordjournals.aje.a114309. PMID:
3485920.
24. Lee BK, Kim Y. Association of blood cadmium with hypertension in the Korean general population: analysis of the 2008-2010 Korean National Health and Nutrition Examination Survey data. Am J Ind Med. 2012; 55:1060–1067. DOI:
10.1002/ajim.22078. PMID:
22692952.
25. Lee BK, Ahn J, Kim NS, Lee CB, Park J, Kim Y. Association of Blood Pressure with Exposure to Lead and Cadmium: Analysis of Data from the 2008-2013 Korean National Health and Nutrition Examination Survey. Biol Trace Elem Res. 2016; 174:40–51. DOI:
10.1007/s12011-016-0699-y. PMID:
27087554.
26. Staessen J, Yeoman WB, Fletcher AE, Markowe HL, Marmot MG, Rose G, Semmence A, Shipley MJ, Bulpitt CJ. Blood lead concentration, renal function, and blood pressure in London civil servants. Br J Ind Med. 1990; 47:442–447. PMID:
1974456.
27. Parkinson DK, Hodgson MJ, Bromet EJ, Dew MA, Connell MM. Occupational lead exposure and blood pressure. Br J Ind Med. 1987; 44:744–748. PMID:
3689706.
28. Morris C, McCarron DA, Bennett WM. Low-level lead exposure, blood pressure, and calcium metabolism. Am J Kidney Dis. 1990; 15:568–574. DOI:
10.1016/S0272-6386(12)80528-2. PMID:
2368697.
29. Park SW, Kim DH. The relationship of low level blood lead to plasma renin activity and blood pressure. Korean J Prev Med. 1991; 24:516–530.
30. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect. 2008; 116:51–56. DOI:
10.1289/ehp.10764. PMID:
18197299.
32. Caciari T, Sancini A, Tomei F, Antetomaso L, Tomei G, Scala B, Sinibaldi F, Di Pastena C, Andreozzi G, Nardone N, Schifano MP, Corbosiero P, Capozzella A, De Sio S, Ciarrocca M. Cadmium blood/urine levels and blood pressure in workers occupationally exposed to urban stressor. Ann Ig. 2012; 24:417–428. PMID:
23193898.
33. Beevers DG, Goldberg A, Campbell BC, Moore MR, Hawthorne VM. Blood-cadmium in hypertensives and normotensives. Lancet. 1976; 2:1222–1224. DOI:
10.1016/S0140-6736(76)91145-4. PMID:
63043.
34. Swaddiwudhipong W, Mahasakpan P, Limpatanachote P, Krintratun S. Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study. Environ Res. 2010; 110:612–616. DOI:
10.1016/j.envres.2010.06.002. PMID:
20561611.
35. Mordukhovich I, Wright RO, Hu H, Amarasiriwardena C, Baccarelli A, Litonjua A, Sparrow D, Vokonas P, Schwartz J. Associations of toenail arsenic, cadmium, mercury, manganese, and lead with blood pressure in the normative aging study. Environ Health Perspect. 2012; 120:98–104. DOI:
10.1289/ehp.1002805. PMID:
21878420.
36. Kam S, Yeh MH, Lee SK, Chun BY. A case-control study for risk factor related to hypertension. Korean J Prev Med. 1991; 24(2):221–231.
37. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street? Hypertension. 2000; 35(3):807–813. DOI:
10.1161/01.HYP.35.3.807. PMID:
10720599.
38. Kim YO. Moderate alcohol consumption does not prevent the hypertension among Korean: the 2001 Korean national health and nutrition examination survey. Korean J Community Nutr. 2006; 11:707–713.
40. Carnethon MR, Evans NS, Church TS, Lewis CE, Schreiner PJ, Jacobs DR Jr, Sternfeld B, Sidney S. Joint associations of physical activity and aerobic fitness on the development of incident hypertension: coronary artery risk development in young adults. Hypertension. 2010; 56:49–55. DOI:
10.1161/HYPERTENSIONAHA.109.147603. PMID:
20516395.
42. de Simone G, Devereux RB, Chinali M, Roman MJ, Best LG, Welty TK, Lee ET. Howard BV; Strong Heart Study Investigators. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension. 2006; 47:162–167. DOI:
10.1161/01.HYP.0000199103.40105.b5. PMID:
16380527.
43. Glover MJ, Greenlund KJ, Ayala C. Croft JB; Racial/ethnic disparities in prevalence, treatment, and control of hypertension-United States 1999-2002. Morb Mortal Wkly Rep. 2005; 54:7–9.
45. Korean Ministry of Health and Welfare (KMOHW). National health examination guideline; KMOHW: Seoul, South Korea.
46. Park WJ, Kim MB, Kim YH, Park RJ, Jang KH, Chae HJ, Moon JD. The relationship of serum CEA levels and type of work in shipyard workers. Korean J Occup Environ Med. 2009; 21:293–300.
47. Braich PS, Howard MK, Singh JS. Dyslipidemia and its association with meibomian gland dysfunction. Int Ophthalmol. 2016; 36:469–476. DOI:
10.1007/s10792-015-0149-4. PMID:
26515235.
50. van Sittert NJ, Ribbens PH, Huisman B, Lugtenburg D. A nine year follow up study of renal effects in workers exposed to cadmium in a zinc ore refinery. Br J Ind Med. 1993; 50:603–612. PMID:
8343421.
51. Roels HA, Lauwerys RR, Bernard AM, Buchet JP, Vos A, Oversteyns M. Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br J Ind Med. 1991; 48:365–374. PMID:
2064974.
52. Chae JM, Lee GS, Lee SS, Ahn KD, Lee BK. A study on the lead exposure of workers in secondary smelting and litharge making Industries. Korean J Occup Environ Med. 1997; 9:131–139.
53. Lee B-K, Kim Y. Association of blood cadmium level with metabolic syndrome after adjustment for confounding by serum ferritin and other factors: 2008-2012 Korean National Health and Nutrition Examination Survey. Biol Trace Elem Res. 2016; 171:6–16. DOI:
10.1007/s12011-015-0499-9. PMID:
26343361.
54. Manser WWT. Plumbum-Karachi Quo Vadis. J of Pakistan Med Ass. 1988;38:227-8.
55. World Health Organization (WHO). Lead. Environmental Health Criteria, Geneva. 1995. vol. 165.
56. Franceschini N, Fry R, Balakrishnan P, Navas-Acien A, Oliver-Williams C, Howard AG, Cole SA, Haack K, Lange EM, Howard BV, Best LG, Francesconi KA, Goessler W, Umans JG, Tellez-Plaza M. Cadmium body burden and increased blood pressure in middle-aged American Indians: the Strong Heart Study. J Hum Hypertens. 2017; 31:225–230. DOI:
10.1038/jhh.2016.67. PMID:
27629244.
57. Satarug S, Nishijo M, Ujjin P, Vanavanitkum Y, Moore MR. Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett. 2005; 157:57–68. DOI:
10.1016/j.toxlet.2005.01.004. PMID:
15795094.
58. Kim NS, Kim JH, Jang BK, Kim HS, Ahn KD, Lee BK. The association of lead biomarkers of lead workers with airborne lead concentration in lead industries. J Korean Soc Occup Environ Hyg. 2007; 17:43–52.
59. Kang MY, Cho SH, Leem YH, Kim JH, Bae SH, Hong YC. Association between cadmium and cognitive function in the elderly. Korean J Occup Environ Med. 2011; 23:309–316.
60. Fleischer N, Mouw R, Vander AJ. Chronic effects of lead on renin and renal sodium excretion. J Lab Clin Med. 1980;95:759–70.
61. Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2008;295:454–65.
62. Schutte R, Nawrot T, Richart T, Thijs L, Roels HA, Van Bortel LM, Struijker-Boudier H, Staessen JA. Arterial structure and function and environmental exposure to cadmium. Occup Environ Med. 2008;65:412–9.
63. Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR. Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett. 2005;157:57–68.
64. Bilgen I, Oner G, Edremitlioğlu M, Alkan Z, Cirrik S. Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. J Basic Clin Physiol Pharmacol. 2003;14:55–76.